Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-10-01

FDA Approved: HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX EXTENDED-RELEASE — Original Application (Cranbury Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved the original application for Hydrocodone polistirex and chlorpheniramine polistirex extended-release, a fixed-dose combination product from Cranbur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX EXTENDED-RELEASE (hydrocodone polistirex and chlorpheniramine polistirex extended-release)

Snippet

ORIG AP for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX EXTENDED-RELEASE (HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX)